Over the last decade, Challenger has become one of the most widely adopted sales methodologies in B2B. It reshaped how organizations talk about insight, value, and customer challenges. Yet, sustained commercial impact remains rare. Across industries, most organizations experience the same pattern: a strong rollout, early enthusiasm, and then gradual erosion. This program doesn’t disappear […]

The Reality Check For the past two decades, B2B organizations have invested billions in sales methodologies designed to improve effectiveness, consistency, and growth. Challenger. MEDDIC. Sandler. RAIN. Richardson. Value Selling. SPIN.  Different language. Different tools. Remarkably similar outcomes. Despite strong intent and significant investment, only 10–20% of organizations achieve sustained behavioral change from any sales methodology. […]

In posts 1and 2 of our 3-part series on The Year-End Sales Push, we revealed the mechanics behind year-end selling—quantified delay and guided decision-making. In post 3, we expose the silent killer of Q4 deals. Most deals don’t die because the buyer says no. They die because the champion can’t get a yes. Executives rarely […]

In our first post on the Year-End Sales Push, we exposed why deals stall at year-end: the unquantified cost of delay.  In this week’s post, we reveal the second truth most sellers never confront. Buyers don’t go dark because they’re disinterested. They go dark because they’re overwhelmed. December is the single most cognitively overloaded month […]

Every December, companies lose millions of dollars not because the market slows down, not because budgets dry up, and not because buyers “need more time.” Deals die because sellers push urgency when buyers desperately need clarity. Research from Gartner confirms that the #1 cause of stalled deals isn’t objection or price—it’s internal misalignment and buyer […]